ZA909755B - Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product - Google Patents

Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product

Info

Publication number
ZA909755B
ZA909755B ZA909755A ZA909755A ZA909755B ZA 909755 B ZA909755 B ZA 909755B ZA 909755 A ZA909755 A ZA 909755A ZA 909755 A ZA909755 A ZA 909755A ZA 909755 B ZA909755 B ZA 909755B
Authority
ZA
South Africa
Prior art keywords
cell cycle
phosphorylation
retinoblastoma gene
gene product
cell proliferation
Prior art date
Application number
ZA909755A
Other languages
English (en)
Inventor
Yuen Kai Fung
Kai Fung Yuen
Original Assignee
Res Dev Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Dev Foundation filed Critical Res Dev Foundation
Publication of ZA909755B publication Critical patent/ZA909755B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/22—Testing for sterility conditions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4736—Retinoblastoma protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Thermal Transfer Or Thermal Recording In General (AREA)
  • Luminescent Compositions (AREA)
ZA909755A 1989-12-07 1990-12-05 Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product ZA909755B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US44728289A 1989-12-07 1989-12-07

Publications (1)

Publication Number Publication Date
ZA909755B true ZA909755B (en) 1991-09-25

Family

ID=23775728

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA909755A ZA909755B (en) 1989-12-07 1990-12-05 Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product

Country Status (17)

Country Link
EP (1) EP0504289B1 (pt)
JP (1) JP3080402B2 (pt)
KR (1) KR100203959B1 (pt)
CN (1) CN1052607A (pt)
AT (1) ATE184653T1 (pt)
AU (1) AU653142B2 (pt)
CA (1) CA2070660A1 (pt)
DE (1) DE69033289T2 (pt)
ES (1) ES2135390T3 (pt)
FI (1) FI922615A (pt)
IE (1) IE904400A1 (pt)
IL (1) IL96575A (pt)
NO (1) NO922168L (pt)
NZ (1) NZ236391A (pt)
PT (1) PT96110A (pt)
WO (1) WO1991009114A1 (pt)
ZA (1) ZA909755B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7223842B1 (en) 1986-08-11 2007-05-29 Massachusetts Eye And Ear Infirmary Detection of proteins whose absence is associated with a neoplasm
US7384735B1 (en) 1986-08-11 2008-06-10 Massachusetts Eye And Ear Infirmary Retinoblastoma nucleic acids
US5851991A (en) * 1987-08-31 1998-12-22 The Regents Of The University Of California Therapeutic use of the retinoblastoma susceptibility gene product
US7105156B1 (en) 1987-09-17 2006-09-12 The Regents Of The University Of California Method of using an adenoviral vector encoding a retinoblastoma protein to treat hyperproliferating cells
TW346397B (en) * 1991-10-17 1998-12-01 Univ California Cell cycle controlling compositions and methods of using same
ZA946595B (en) * 1993-09-03 1996-02-28 Res Dev Foundation Mutants of the retinoblastoma and P53 genes and uses thereof
US5969120A (en) * 1993-09-03 1999-10-19 Research Development Foundation Mutants of the RB and P53 genes
GB9506050D0 (en) 1995-03-24 1995-05-10 Osteometer A S Assaying collagen fragments in body fluids
DE69520111T2 (de) 1994-10-17 2001-09-06 Osteometer Biotech As Herlev Schätzung des Fragmentierungsmusters von Kollagen in Körperflüssigkeiten und Diagnose von mit dem Kollagenmetabolismus zusammenhängenden Störungen
AU4502096A (en) * 1994-11-11 1996-06-06 Arch Development Corporation A process of inhibiting non-neoplastic pathological cell proliferation
US6107047A (en) * 1996-03-21 2000-08-22 Osteometer Biotech A/S Assaying protein fragments in body fluids
GB9617616D0 (en) 1996-08-22 1996-10-02 Osteometer Biotech As Assaying protein fragments in body fluids
WO1998026286A2 (en) 1996-12-09 1998-06-18 Osteometer Biotech A/S Sandwich assays for collagen type i fragments
US6117646A (en) * 1997-09-22 2000-09-12 Osteometer Biotech A/S Assaying protein fragments in body fluids
JP6142068B1 (ja) * 2016-12-13 2017-06-07 株式会社マスダック サンドウィッチパンケーキ製造装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5888801A (ja) * 1981-11-20 1983-05-27 Hitachi Ltd 磁気デイスク記憶装置
US4694023A (en) * 1982-06-28 1987-09-15 Usv Pharmaceutical Corporation Alpha-alkyl polyolefinic carboxylic acids and derivatives thereof useful in the treatment of psoriasis and allergic responses
US4797762A (en) * 1987-09-22 1989-01-10 Micropolis Corporation Stress free winchester drive shaft mounting

Also Published As

Publication number Publication date
JP3080402B2 (ja) 2000-08-28
DE69033289T2 (de) 2000-01-05
NO922168D0 (no) 1992-06-01
NO922168L (no) 1992-07-15
EP0504289B1 (en) 1999-09-15
JPH05503421A (ja) 1993-06-10
ATE184653T1 (de) 1999-10-15
CN1052607A (zh) 1991-07-03
PT96110A (pt) 1991-09-30
IL96575A (en) 1995-05-26
FI922615A0 (fi) 1992-06-05
WO1991009114A1 (en) 1991-06-27
ES2135390T3 (es) 1999-11-01
NZ236391A (en) 2001-07-27
IL96575A0 (en) 1991-09-16
EP0504289A4 (en) 1993-03-31
EP0504289A1 (en) 1992-09-23
AU653142B2 (en) 1994-09-22
AU7038991A (en) 1991-07-18
KR100203959B1 (ko) 1999-06-15
DE69033289D1 (de) 1999-10-21
FI922615A (fi) 1992-06-05
IE904400A1 (en) 1991-06-19
CA2070660A1 (en) 1991-06-08

Similar Documents

Publication Publication Date Title
ZA909755B (en) Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product
AU512694B2 (en) Sole construction for articles of footwear
GB2147191B (en) Modular substrate sole for footwear
PT71853A (en) Shoe soles and process for its manufacture
SE8302774L (sv) Raffinerad, detoxifierad endotoxinprodukt samt sett att framstella detsamma jemte en terapeutisk komposition som innehaller produkten
AU544015B2 (en) Two-zone process for biological treatment of waste water
GB2075330B (en) Moulding soles to shoe uppers
NZ189233A (en) Comminuted meat extender
IT1193498B (it) Procedimento di separazione di effluente prodotto da reazione in fase mista
EP0145560A3 (en) Treating process for leather, particularly for leather shoe-uppers, shoe-uppers and shoes manufactured according to this process
FR2635611B1 (fr) Procede de neutralisation des atomes accepteurs dans inp de type p
GR75669B (pt)
AU524274B2 (en) Treating asbestos diaphragms for electrolytic cells
YU192879A (en) Process for performing enzymatic determinations
ONO et al. Variation of two forms of DNA polymerase-α during a HeLa cell cycle
AU6423480A (en) Locking shoes to pedals of cycles
GB9216021D0 (en) Improvements to footwear soles
AU522451B2 (en) Improvements in or relating to methods of stiffening shoe uppers
JPS53136591A (en) Preparation of adenosine-5'-triphosphoric acid
JPS561102A (en) Upper member of footwear such as shoe * sandal or slipper and method and product
JPS55104206A (en) Cosmetic containing enzyme
EP0289616A4 (en) METHOD FOR PROPAGING ANIMAL CELLS.
JPS555625A (en) Preparation of soles for boots for ladies
JPS54126300A (en) Method of oonverting leather type phosphazene polymer into eiastmer type phosphazene polymer
ES8100253A1 (es) Procedimiento de obtencion de un derivado de un l-o(-aminoacido con accion terapeutica)